AveXis, Inc., a Novartis Company, is a clinical-stage gene therapy biotechnology company, focused on the treatment of neurological diseases.
News
- UTSA welcomes gene therapy pioneer Brian Kaspar for April 10 Distinguished Lecture
- Waterfront Capital Partners Has Boosted By $5.40 Million Its Retail Pptys Amer (RPAI) Position ...
CURATIVE BIOSCIENCES INC (OTCMKTS:CBDX) had an increase of ... Oaks In The San Antonio MSA; 14/05/2018 – Resolution Capital Buys New ...
- UT Health San Antonio launching new technology accelerator
TechNovum will get support from the San Antonio Life Sciences Institute, a joint program of UT Health San Antonio and the University of Texas at San ...
- GameStop falls while Dave & Buster's and Blue Apron rise
The biotechnology company presented a series of positive early studies for potential cancer treatments. Acuity Brands Inc., up $10.90 to $134.79.
- Mount Sinai Will Develop Digital Health Institute: Grants Roundup
$2.5 million to the University of Texas at San Antonio to establish a ... UT Health San Antonio that will preserve specimens for biomedical research and ...